1. Main page
  2. Healthcare & Medical
  3. Ascletis

Ascletis

2 Decision Makers · 5 Verified Contacts

ascletis.com
📍 Chapel Hill, North Carolina, United StatesHealthcare & Medical🗓 Est. 2011👥 251–500 employees

About Ascletis

Ascletis is a specialty therapeutics company developing therapeutics for the treatment of cancer and infectious diseases.

Leadership & Decision Makers

Contact details of 2 Ascletis decision makers

Jinzi Wu

Founder & President , CEO

Judy Wu

Vice President

Team & Specialists

Contact details of 3 Ascletis team members

Yuemei Yan

VP, Sales

Vivian Chen

VP, Corporate Affairs

John P. Gargiulo

CBO

General Emails

General company emails, e.g. customer support lines

    bd@ascletis.com

    Unclassified inbox

    u003eir@ascletis.com

    Investor Relations

    jinzi.wu@ascletis.com

    Unclassified inbox

    pr@ascletis.com

    Unclassified inbox

    u003epr@ascletis.com

    Unclassified inbox

Verify Ascletis Emails

Similar Companies like Ascletis

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Alexion Pharmaceuticals

alexion.com
Biotechnology · Cheshire, Connecticut, United States · Est. 1992 · 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Medtronic

medtronic.com
Biotechnology · Minneapolis, MN · Est. 1949 · Above 10001 employees

HQ: Minneapolis, MN

Mount Sinai Health System

mountsinai.org
Healthcare & Medical · New York, NY · Est. 1997 · Above 10001 employees

HQ: New York, NY

DaVita

davita.com
Healthcare & Medical · Denver, CO · Est. 1979 · Above 10001 employees

HQ: Denver, CO

Explore similar firms in the Healthcare & Medical sector

Company Info

Last updated: 28/07/2025

ascletis.com

1-919-328-0212

Chapel Hill, North Carolina, United States

Specialization: Therapeutics,
Legal Name: Ascletis Pharma Inc.
Business Type: Public
Employees: 251-500
Rounds: Series B
Founded Date: 2011
Number of Exits: 1
Company Type: For Profit
Stock Symbol: OTCPINK:ASCLF
Operating Status: Active
Last Funding Type: Series B
Phone Number: 1-919-328-0212
Last Investment Activity: Apr 8, 2024
Investments Activity: Apr 8, 2024 Apr 5, 2024 Apr 3, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.